Sargent Investment Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.37M Buy
15,782
+2,245
+17% +$215K 0.18% 102
2025
Q4
$1.3M Buy
13,537
+548
+4% +$53.2K 0.16% 101
2025
Q3
$1.24M Buy
12,989
+2,790
+27% +$256K 0.18% 88
2025
Q2
$911K Buy
10,199
+2,951
+41% +$250K 0.12% 108
2025
Q1
$651K Buy
7,248
+1,704
+31% +$152K 0.1% 122
2024
Q4
$453K Buy
+5,544
New +$480K 0.07% 140

Other funds holding MDT

Sargent Investment Group's MDT Position: Q1 2026 in Review

Sargent Investment Group increased its Medtronic (MDT) stake by 17% in Q1 2026, buying an estimated $215K and bringing the position to 15,782 shares worth $1.37M. The position accounts for 0.18% of the portfolio, ranked #102.

Sargent Investment Group first reported a position in MDT in Q4 2024 and has held it in 6 quarters since. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Sargent Investment Group held 15,782 shares of Medtronic worth $1.37M as of Q1 2026.
  • Sargent Investment Group bought 2,245 Medtronic shares in Q1 2026, an estimated $215K.
  • Medtronic made up 0.18% of Sargent Investment Group's portfolio in Q1 2026, its #102 holding.
  • Sargent Investment Group first reported a position in Medtronic in Q4 2024 and has held it in 6 quarters since.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.